Helping our patient communities and advancing knowledge in our therapy areas is part of our corporate responsibility.
It is our mission to discover, develop, and deliver innovative therapies that improve patients' quality of life.
We work with government authorities to ensure patients have access to care while also funding medical research.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.
Every day at CSL Behring, we work as if someone’s life depends on it, because it does.
CSL Behring biotherapies are manufactured in state-of-the-art facilities under stringent, controlled conditions.
Help us deliver on our promise to save lives and protect the health of people.
Make your well-being a priority. It's important and so are you.
Women who have the bleeding disorder often go undiagnosed, Duke doctor says.
How John Vieke’s daughter helped him see his rare disease in a new light.
Nominations are open for this year’s Junior National Championship.
First episode marks World Hemophilia Day, features Duke University physician.
Patient advocates share stories to empower others living with similar conditions.
Von Willebrand Disease didn’t stop Mary Ann from finishing 15 marathons.
A team representing the National Hemophilia Foundation hits the pavement.
Tips from Kim Walsh, who is living with von Willebrand Disease
From rock to hip-hop to show tunes, all genres make the playlist.
One VWD patient’s tips for a life without limits.
Hint: It’s not that I have von Willebrand Disease
Von Willebrand disease patient Roberta Smith’s “Promising Tips.”
Popular search terms:
Americas
Asia Pacific
Europe
